Our Health Care Litigation Team discusses a District of Massachusetts case holding that allows the government to switch liability theories in its False Claims Act lawsuit against Regeneron Pharmaceuticals....more
8/11/2025
/ Anti-Kickback Statute ,
Department of Justice (DOJ) ,
Discovery ,
False Claims Act (FCA) ,
Healthcare Fraud ,
Litigation Strategies ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Regeneron ,
Summary Judgment
An amicus brief in an FCA suit indicates that the government is serious about applying the Granston Memo and invoking its statutory authority to dismiss cases. Our White Collar, Government & Internal Investigations and Health...more